Jean-Marc Hoffmann – Physician-Investigator / Resident in Pharmaceutical Medicine, Clinical Trials Center – Universitätsspital Zürich | LinkedIn
![Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine](https://www.researchgate.net/publication/333230897/figure/fig1/AS:760822112473089@1558405535931/Influence-of-PipFcB-on-the-cytotoxic-capacity-of-CARTs-against-CD19-cells-Cytotoxicity_Q320.jpg)
Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine
Jean-Marc Hoffmann – Physician-Investigator / Resident in Pharmaceutical Medicine, Clinical Trials Center – Universitätsspital Zürich | LinkedIn
![Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine](https://i1.rgstatic.net/ii/profile.image/272779677270029-1442047151549_Q128/Laurenz-Schmitt.jpg)
Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine
![Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine](https://www.researchgate.net/publication/333669255/figure/fig5/AS:941421385220105@1601463757189/Exhaustion-and-homing-markers-of-NY-ESO-1-specific-T-cells-NY-ESO-1-specific-T-cells_Q320.jpg)
Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine
![Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine Jean-Marc HOFFMANN | Physician-Investigator / Resident in Pharmaceutical Medicine | Doctor of Medicine](https://www.researchgate.net/profile/Michael-Schmitt-31/publication/326498325/figure/tbl1/AS:670381333549082@1536842773902/Screening-of-HDs-and-CLL-patients-P-for-lymphocyte-subsets-within-PBMCs_Q320.jpg)